Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive logo
$98.65 +1.77 (+1.82%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$98.10 -0.55 (-0.55%)
As of 11/20/2026 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
7
Buy
13

Based on 20 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 20 analysts, 7 have given a hold rating, and 13 have given a buy rating for CL.

Consensus Price Target

$101.22
2.61% Upside
According to the 20 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $101.22. The highest price target for CL is $112.00, while the lowest price target for CL is $89.00. The average price target represents a forecasted upside of 2.61% from the current price of $98.65.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CL Analyst Ratings Over Time

TypeCurrent Forecast
11/22/25 to 11/22/26
1 Month Ago
10/23/25 to 10/23/26
3 Months Ago
8/24/25 to 8/24/26
1 Year Ago
11/22/24 to 11/22/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
13 Buy rating(s)
12 Buy rating(s)
9 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
7 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$101.22$98.00$98.56$89.75
Forecasted Upside2.61% Upside4.14% Upside6.59% Upside10.84% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Colgate-Palmolive Stock vs. The Competition

TypeColgate-PalmoliveConsumer Staples CompaniesBroader Market
Consensus Rating Score
2.65
2.21
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside2.61% Upside42.35% Upside22.05% Upside
News Sentiment Rating
Positive News

See Recent CL News
Neutral News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
11/3/2026
Barclays PLC logo
Barclays
3 of 5 stars
Lauren Lieberman
Lauren Lieberman
3 of 5 stars
Boost TargetEqual Weight$87.00 ➝ $95.00-2.65%
11/2/2026
TD Cowen logo
TD Cowen
3 of 5 stars
Robert Moskow
Robert Moskow
Not Rated
Boost TargetHold$90.00 ➝ $97.00+0.48%
11/2/2026
Bank of America Corporation logo
Bank of America
4 of 5 stars
Bryan Spillane
Bryan Spillane
2 of 5 stars
Boost TargetBuy$100.00 ➝ $105.00+10.12%
11/2/2026Boost TargetBuy$106.00 ➝ $112.00+17.46%
11/2/2026Reiterated RatingOutperform$97.00 ➝ $108.00+12.06%
11/2/2026Boost TargetOverweight$104.00 ➝ $111.00+15.18%
11/2/2026Lower TargetOverweight$104.00 ➝ $102.00+5.76%
11/2/2026Boost TargetOutperform$104.00 ➝ $105.00+8.82%
11/2/2026Boost TargetEqual Weight$90.00 ➝ $95.00-0.37%
10/8/2026 Boost TargetOutperform$100.00 ➝ $101.00+14.52%
10/2/2026 DowngradeBuy (B-) ➝ Hold (C+)
9/21/2026Lower TargetOverweight$98.00 ➝ $95.00+8.57%
8/13/2026Reiterated RatingMarket Perform
8/3/2026Reiterated RatingBuy$99.00 ➝ $101.00+10.42%
8/3/2026 Reiterated RatingHold$88.00 ➝ $89.00-2.51%
8/3/2026 Boost TargetOutperform$100.00 ➝ $102.00+15.65%
7/14/2026Boost TargetBuy$105.00 ➝ $110.00+18.09%
5/1/2026 Reiterated RatingBuy$100.00 ➝ $98.00+12.45%
4/21/2026UpgradeNeutral ➝ Buy$93.00 ➝ $100.00+19.78%
12/11/2025Reiterated RatingBuy ➝ Hold
10/30/2025 Lower Target$92.00 ➝ $88.00-0.22%
2/3/2025Lower TargetHold$95.00 ➝ $93.00+7.86%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 03:48 PM ET.


Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, November 18, 2026. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

Colgate-Palmolive
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

  • Colgate-Palmolive recently reported third-quarter earnings that exceeded analyst expectations, posting $0.97 in earnings per share against a consensus estimate of $0.93, while revenue of $5.37 billion also surpassed the $5.34 billion forecast, demonstrating strong operational performance and top-line growth of 4.6% year-over-year.
  • The stock is currently trading at $98.76, which is near its 52-week high of $101.81, and the company maintains a low beta of 0.31, indicating that its share price is significantly less volatile than the broader market, making it a stable defensive holding for risk-averse investors.
  • With a dividend yield of 2.13% and a recent quarterly dividend payment of $0.53 per share, the company offers a consistent income stream, supported by a payout ratio of 83.14% that remains manageable relative to its earnings power.
  • Analyst sentiment remains positive with a consensus rating of "Moderate Buy" from twenty firms, and the average price target of $101.22 suggests potential upside from the current price, reinforced by recent target price increases from major institutions like UBS Group and Bank of America.
  • Short interest has decreased month-over-month, with shares shorted dropping to 18.54 million from 24.04 million in the previous period, suggesting that bearish sentiment is fading and that institutional investors are increasingly confident in the company's trajectory.

Colgate-Palmolive
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

  • Company insiders have been actively selling shares, with CEO Noel Wallace selling 20,000 shares in November and EVP Gregory Malcolm selling 4,100 shares, contributing to a total of 77,414 shares sold by insiders over the last ninety days, which may signal a lack of confidence in near-term stock appreciation.
  • The company carries a high debt-to-equity ratio of 11.23, indicating significant leverage that could limit financial flexibility or increase interest expense burdens if interest rates remain elevated or if earnings growth slows.
  • Despite recent earnings beats, the stock's price-to-earnings ratio of 25.67 is relatively high for a consumer staples company, suggesting that the market may be pricing in optimistic growth expectations that could be difficult to sustain given the mature nature of its core product lines.
  • The dividend payout ratio stands at 83.14%, which is a high percentage of earnings being distributed to shareholders, potentially leaving less capital available for reinvestment in growth initiatives or debt reduction compared to peers with lower payout ratios.
  • While the stock has reached new 52-week highs, the current price of $98.76 is below the average analyst target price of $101.22, but the limited upside of approximately 2.5% suggests that much of the positive news may already be priced into the stock, offering limited room for further gains in the short term.

CL Forecast - Frequently Asked Questions

According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $101.22, with a high forecast of $112.00 and a low forecast of $89.00.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 7 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CL shares.

According to analysts, Colgate-Palmolive's stock has a predicted upside of 2.61% based on their 12-month stock forecasts.

Over the previous 90 days, Colgate-Palmolive's stock had 1 upgrade and 1 downgrade by analysts.

Analysts like Colgate-Palmolive more than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CL compares to other companies.


MarketBeat monitors more than a dozen sources for Colgate-Palmolive analyst ratings, with the most recent rating issued on 11/3/2026.
From Our Partners